Subingsubing, Danilo C.

HRN: 03-99-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2026
CEFTRIAXONE 1G (VIAL)
08/15/2026
08/21/2026
IV
2g
OD
Multiple Abrasions
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: